Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation

IF 2.1 4区医学 Q3 HEMATOLOGY Leukemia research Pub Date : 2024-02-01 DOI:10.1016/j.leukres.2024.107439

Lara Boucher, Laura Rozalska, Nathalie Sorel, Gaëlle Olivier, Maria Pilar Gallego Hernanz, Emilie Cayssials, Anna Raimbault, Jean-Claude Chomel

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

慢性髓性白血病继发性融合的出现是酪氨酸激酶抑制剂耐药性和暴发性危机转化的驱动因素

无摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.

期刊最新文献

Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population Epidemiological and genetic insights into the co-occurrence of cutaneous melanoma and hematologic malignancies: A meta-analytic review In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology Editorial Board The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysis